封面
市場調查報告書
商品編碼
2051377

血糖值監測市場:按類型、組件、最終用戶和地區分類。

Blood Glucose Monitoring Market, By Type, By Component, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,血糖值監測市場規模將達到230.2億美元,到2033年將達到465.9億美元。預計從2026年到2033年,該市場將以10.6%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 2320億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 10.60% 2033年市場規模預測: 465.9億美元

血糖值監測在糖尿病管理中至關重要,因為它使患者能夠定期檢查血糖值並採取相應的措施。自我監測設備的普及和價格的降低,以及人們對糖尿病照護意識的不斷提高,正在推動血糖值監測解決方案在全球範圍內的廣泛應用。此外,技術的進步催生了精度更高、使用更便利、連接性更強的創新監測設備,預計這將進一步加速未來幾年的市場成長。

市場動態

全球血糖值監測市場正穩步成長,這主要得益於全球糖尿病患者數量的增加以及人們對糖尿病管理日益成長的關注。肥胖症盛行率上升和久坐不動的生活方式等多種因素加劇了全球糖尿病負擔,從而推動了血糖值監測設備的普及。此外,已開發地區方便用戶使用且價格合理的測量解決方案的開發,以及有利的保險報銷政策,也促進了自我監測設備的使用。然而,尤其是在開發中國家,先進血糖儀的高成本仍然是一個主要挑戰。此外,網路威脅和資料外洩的風險也可能阻礙連網監測設備的普及。儘管如此,包括微創連續血糖監測系統在內的持續技術升級,為市場相關人員帶來了良好的前景。

本次調查的主要特點

  • 本研究確定了各細分市場的潛在收入成長機會,並說明了該市場具有吸引力的投資提案矩陣。
  • 此外,本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
  • 本研究根據以下參數對全球血糖值監測市場的主要參與者進行了分析:公司概況、產品系列、主要亮點、財務績效和策略。
  • 透過利用本報告中的見解,企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
  • 全球血糖值監測市場包括該行業的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用全球血糖值監測市場分析中使用的各種策略矩陣,更輕鬆地做出決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 機會
  • 影響分析
  • 市場趨勢
  • 近期趨勢
  • 監管趨勢
  • 技術進步
  • 製造商利潤
  • 收購與合作趨勢
  • 產品上市及核准
  • 資金籌措及投資
  • PEST分析
  • 波特的分析

第4章 全球血糖值監測市場:依類型分類,2021-2033年

  • 概述
  • 自測血糖儀
  • 連續血糖監測設備
  • 瞬感血糖儀

第5章 全球血糖值監測市場:依組件分類,2021-2033年

  • 概述
  • 血糖儀
  • 測試條
  • Lancets
  • 感應器
  • 其他

第6章 全球血糖值監測市場:依最終用戶分類,2021-2033年

  • 概述
  • 醫院
  • 居家醫療
  • 門診部
  • 其他

第7章 全球血糖值監測市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第8章 競爭情勢

  • 公司簡介
    • Medtronic
    • ACON Laboratories, Inc.
    • Senseonics, Inc.
    • Medisana AG
    • Bionime Corporation
    • AgaMatrix Inc.
    • ARKRAY, Inc.
    • Rossmax International Ltd.
    • Dexcom, Inc.
    • Nipro Group
    • B. Braun SE
    • Nova Biomedical
    • LifeScan IP Holdings, LLC
    • Ascensia Diabetes Care Holdings AG
    • Nemaura
    • Terumo Corporation
    • F. Hoffmann-La Roche Ltd.

第9章 分析師觀點

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第10章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI5382

Blood Glucose Monitoring Market is estimated to be valued at USD 23.02 Bn in 2026 and is expected to reach USD 46.59 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.6% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 23.02 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 10.60% 2033 Value Projection: USD 46.59 Bn

Blood glucose monitoring is crucial for managing diabetes as it helps patients monitor their blood sugar levels and take corrective measures on a regular basis. Easy availability and affordability of self-monitoring devices along with growing awareness about diabetes care have been driving the greater adoption of blood glucose monitoring solutions globally. In addition, technological advancements leading to the development of innovative monitoring devices with enhanced features for accuracy, convenience, and connectivity are expected to further propel the market growth in the coming years.

Market Dynamics

The global blood glucose monitoring market has been witnessing steady growth attributed to rising diabetic population worldwide coupled with growing focus on diabetes management. Various factors, such as increasing prevalence of obesity and sedentary lifestyles, are contributing to the diabetes burden globally, which, in turn, is driving the adoption of blood glucose monitoring devices. Additionally, the development of user-friendly and affordable monitoring solutions along with favorable reimbursement policies in developed regions are encouraging the greater uptake of self-monitoring devices. However, high costs associated with advanced blood glucose monitors remains a key challenge, especially in developing countries. Moreover, vulnerabilities to cyber threats and data breaches could hamper the transition towards connected monitoring devices. Nonetheless, ongoing technological upgrades including the development of minimally invasive continuous glucose monitoring systems presents bright prospects for market players.

Key Features of the Study

  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global blood glucose monitoring market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study Medtronic, ACON Laboratories, Inc., Senseonics, Inc., Medisana AG, Bionime Corporation, AgaMatrix Inc., ARKRAY, Inc., Rossmax International Ltd., Dexcom, Inc., Nipro Group, B. Braun SE, Nova Biomedical, LifeScan IP Holdings, LLC, Ascensia Diabetes Care Holdings AG, Nemaura, Terumo Corporation, and Hoffmann-La Roche Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global blood glucose monitoring market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood glucose monitoring market.

Market Segmentation

  • Type Insights (Revenue, USD Bn, 2021 - 2033)
  • Self-monitoring blood glucose devices
  • Continuous glucose monitoring devices
  • Flash glucose monitoring devices
  • Component Insights (Revenue, USD Bn, 2021 - 2033)
  • Glucometer devices
  • Test strips
  • Lancets
  • Sensors
  • Others
  • End User Insights (Revenue, USD Bn, 2021 - 2033)
  • Hospitals
  • Homecare Settings
  • Ambulatory Care Settings
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Medtronic
  • ACON Laboratories, Inc.
  • Senseonics, Inc.
  • Medisana AG
  • Bionime Corporation
  • AgaMatrix Inc.
  • ARKRAY, Inc.
  • Rossmax International Ltd.
  • Dexcom, Inc.
  • Nipro Group
  • B. Braun SE
  • Nova Biomedical
  • LifeScan IP Holdings, LLC
  • Ascensia Diabetes Care Holdings AG
  • Nemaura
  • Terumo Corporation
  • F. Hoffmann-La Roche Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Component
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Regulatory Scenario
  • Technological Advancements
  • Manufacturer Revenue
  • Acquisitions and Partnerships Scenario
  • Product Launches/Approvals
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Blood Glucose Monitoring Market, By Type, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Self-monitoring blood glucose devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Continuous glucose monitoring devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Flash glucose monitoring devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Blood Glucose Monitoring Market, By Component, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Glucometer devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Test strips
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Lancets
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Sensors
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Blood Glucose Monitoring Market, By End User, 2021 - 2033, (USD Bn)

  • Overview
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2021 - 2033
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Homecare Settings
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Ambulatory Care Settings
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Blood Glucose Monitoring Market, By Region, 2021 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021 - 2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Component, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • Medtronic
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ACON Laboratories, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Senseonics, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Medisana AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Bionime Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • AgaMatrix Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ARKRAY, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Rossmax International Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Dexcom, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Nipro Group
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • B. Braun SE
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Nova Biomedical
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • LifeScan IP Holdings, LLC
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Ascensia Diabetes Care Holdings AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Nemaura
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Terumo Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • F. Hoffmann-La Roche Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

9. Analyst View

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact